Michael Bergel
Impact in
-
- Genomics and Chromatin Dynamics
- Histone Deacetylase Inhibitors Research
- Ubiquitin and proteasome pathways
- RNA Research and Splicing
- Epigenetics and DNA Methylation
- Protein Degradation and Inhibitors
- Cancer-related gene regulation
Papers in
-
- Genomics and Chromatin Dynamics 5
- Histone Deacetylase Inhibitors Research 4
- Ubiquitin and proteasome pathways 3
- Protein Degradation and Inhibitors 2
- RNA Research and Splicing 2
- Surgery 4
- Bariatric Surgery and Outcomes 4
- Co-authors
- Michael Bustin (5 shared papers)Yoshihiro Nakatani (3 shared papers)Julio E. Herrera (3 shared papers)Yaffa Rubinstein (2 shared papers)Jae‐Hwan Lim (2 shared papers)Kazuyasu Sakaguchi (1 shared paper)Katherine L. West (1 shared paper)Yuri V. Postnikov (1 shared paper)
- Journals
- Journal of Biological Chemistry (3 papers)iScience (1 paper)Molecular Cancer Therapeutics (1 paper)Molecular Carcinogenesis (1 paper)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- IsraelUnited StatesSouth Korea
In The Last Decade
Michael Bergel
21 papers receiving 396 citations
Peers
Comparison fields: 5 of 67
- Molecular Biology 301
- Cancer Research 38
- Geriatrics and Gerontology 9
- Oncology 62
- Immunology 45
Countries citing papers authored by Michael Bergel
This map shows the geographic impact of Michael Bergel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Bergel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Bergel more than expected).
Fields of papers citing papers by Michael Bergel
This network shows the impact of papers produced by Michael Bergel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Bergel. The network helps show where Michael Bergel may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Bergel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 79 | |
| 2 | 1999 | 78 | |
| 3 | 2000 | 60 | |
| 4 | 1997 | 56 | |
| 5 | 1990 | 18 | |
| 6 | 1998 | 18 | |
| 7 | 2021 | 18 | |
| 8 | 2009 | 15 | |
| 9 | 2015 | 12 | |
| 10 | 2019 | 8 | |
| 11 | 2020 | 6 | |
| 12 | 1993 | 5 | |
| 13 | 1997 | 5 | |
| 14 | 2022 | 4 | |
| 15 | 2021 | 4 | |
| 16 | 2023 | 3 | |
| 17 | 2022 | 3 | |
| 18 | 2022 | 2 | |
| 19 | 1991 | 2 | |
| 20 | 2022 | 1 |
About Michael Bergel
Michael Bergel is a scholar working on Molecular Biology, Surgery, Physiology, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 21 papers that have together received 398 indexed citations. Recurring topics across this work include Genomics and Chromatin Dynamics (5 papers), Bariatric Surgery and Outcomes (4 papers), Histone Deacetylase Inhibitors Research (4 papers), Diet and metabolism studies (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Ubiquitin and proteasome pathways (3 papers), Protein Degradation and Inhibitors (2 papers) and RNA Research and Splicing (2 papers). The work is most often cited by research in Molecular Biology (301 citations), Cancer Research (38 citations), Geriatrics and Gerontology (9 citations), Oncology (62 citations) and Immunology (45 citations). Michael Bergel has collaborated with scholars based in Israel, United States and South Korea. Frequent co-authors include Michael Bustin, Yoshihiro Nakatani, Julio E. Herrera, Yaffa Rubinstein, Jae‐Hwan Lim, Kazuyasu Sakaguchi, Katherine L. West, Yuri V. Postnikov, Lothar Trieschmann and Xiang-Jiao Yang. Their work appears in journals such as Journal of Biological Chemistry, iScience, Molecular Cancer Therapeutics, Molecular Carcinogenesis and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.